United States Pertuzumab Market Report & Forecast 2021-2027

Publisher Name :
Date: 12-Oct-2021
No. of pages: 92
Inquire Before Buying

United States Pertuzumab Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (MT)

United States Pertuzumab Market Segment Percentages, By Type, 2020 (%)

- Human Source

- Animal Source

United States Pertuzumab Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (MT)

United States Pertuzumab Market Segment Percentages, By Application, 2020 (%)

- Hospital

- Medical Center

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Pertuzumab revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies Pertuzumab revenues share in United States market, 2020 (%)

Key companies Pertuzumab sales in United States market, 2016-2021 (Estimated), (MT)

Key companies Pertuzumab sales share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Novartis AG

- Pfizer

- Abnova Corporation

- InvivoGen

- Celltrion

- Biocon Limited

- Bio-Techne

United States Pertuzumab Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Pertuzumab Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Pertuzumab Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Pertuzumab Overall Market Size
2.1 United States Pertuzumab Market Size: 2021 VS 2027
2.2 United States Pertuzumab Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Pertuzumab Sales: 2016-2027
3 Company Landscape
3.1 Top Pertuzumab Players in United States Market
3.2 Top United States Pertuzumab Companies Ranked by Revenue
3.3 United States Pertuzumab Revenue by Companies
3.4 United States Pertuzumab Sales by Companies
3.5 United States Pertuzumab Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Pertuzumab Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Pertuzumab Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pertuzumab Players in United States Market
3.8.1 List of Tier 1 Pertuzumab Companies in United States
3.8.2 List of Tier 2 and Tier 3 Pertuzumab Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Pertuzumab Market Size Markets, 2021 & 2027
4.1.2 Human Source
4.1.3 Animal Source
4.2 By Type - United States Pertuzumab Revenue & Forecasts
4.2.1 By Type - United States Pertuzumab Revenue, 2016-2021
4.2.2 By Type - United States Pertuzumab Revenue, 2022-2027
4.2.3 By Type - United States Pertuzumab Revenue Market Share, 2016-2027
4.3 By Type - United States Pertuzumab Sales & Forecasts
4.3.1 By Type - United States Pertuzumab Sales, 2016-2021
4.3.2 By Type - United States Pertuzumab Sales, 2022-2027
4.3.3 By Type - United States Pertuzumab Sales Market Share, 2016-2027
4.4 By Type - United States Pertuzumab Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Pertuzumab Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Medical Center
5.2 By Application - United States Pertuzumab Revenue & Forecasts
5.2.1 By Application - United States Pertuzumab Revenue, 2016-2021
5.2.2 By Application - United States Pertuzumab Revenue, 2022-2027
5.2.3 By Application - United States Pertuzumab Revenue Market Share, 2016-2027
5.3 By Application - United States Pertuzumab Sales & Forecasts
5.3.1 By Application - United States Pertuzumab Sales, 2016-2021
5.3.2 By Application - United States Pertuzumab Sales, 2022-2027
5.3.3 By Application - United States Pertuzumab Sales Market Share, 2016-2027
5.4 By Application - United States Pertuzumab Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Novartis AG
6.1.1 Novartis AG Corporation Information
6.1.2 Novartis AG Overview
6.1.3 Novartis AG Pertuzumab Sales and Revenue in United States Market (2016-2021)
6.1.4 Novartis AG Pertuzumab Product Description
6.1.5 Novartis AG Recent Developments
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Overview
6.2.3 Pfizer Pertuzumab Sales and Revenue in United States Market (2016-2021)
6.2.4 Pfizer Pertuzumab Product Description
6.2.5 Pfizer Recent Developments
6.3 Abnova Corporation
6.3.1 Abnova Corporation Corporation Information
6.3.2 Abnova Corporation Overview
6.3.3 Abnova Corporation Pertuzumab Sales and Revenue in United States Market (2016-2021)
6.3.4 Abnova Corporation Pertuzumab Product Description
6.3.5 Abnova Corporation Recent Developments
6.4 InvivoGen
6.4.1 InvivoGen Corporation Information
6.4.2 InvivoGen Overview
6.4.3 InvivoGen Pertuzumab Sales and Revenue in United States Market (2016-2021)
6.4.4 InvivoGen Pertuzumab Product Description
6.4.5 InvivoGen Recent Developments
6.5 Celltrion
6.5.1 Celltrion Corporation Information
6.5.2 Celltrion Overview
6.5.3 Celltrion Pertuzumab Sales and Revenue in United States Market (2016-2021)
6.5.4 Celltrion Pertuzumab Product Description
6.5.5 Celltrion Recent Developments
6.6 Biocon Limited
6.6.1 Biocon Limited Corporation Information
6.6.2 Biocon Limited Overview
6.6.3 Biocon Limited Pertuzumab Sales and Revenue in United States Market (2016-2021)
6.6.4 Biocon Limited Pertuzumab Product Description
6.6.5 Biocon Limited Recent Developments
6.7 Bio-Techne
6.7.1 Bio-Techne Corporation Information
6.7.2 Bio-Techne Overview
6.7.3 Bio-Techne Pertuzumab Sales and Revenue in United States Market (2016-2021)
6.7.4 Bio-Techne Pertuzumab Product Description
6.7.5 Bio-Techne Recent Developments
7 United States Pertuzumab Production Capacity, Analysis
7.1 United States Pertuzumab Production Capacity, 2016-2027
7.2 Pertuzumab Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Pertuzumab Supply Chain Analysis
9.1 Pertuzumab Industry Value Chain
9.2 Pertuzumab Upstream Market
9.3 Pertuzumab Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Pertuzumab Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Pertuzumab in United States Market
Table 2. Top Pertuzumab Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Pertuzumab Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Pertuzumab Revenue Share by Companies, 2016-2021
Table 5. United States Pertuzumab Sales by Companies, (MT), 2016-2021
Table 6. United States Pertuzumab Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Pertuzumab Price (2016-2021) & (USD/MT)
Table 8. Manufacturers Pertuzumab Product Type
Table 9. List of Tier 1 Pertuzumab Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Pertuzumab Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Human Source
Table 12. Major Manufacturers of Animal Source
Table 13. By Type - United States Pertuzumab Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Pertuzumab Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Pertuzumab Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Pertuzumab Sales (MT), 2016-2021
Table 17. By Type - United States Pertuzumab Sales (MT), 2022-2027
Table 18. By Application - United States Pertuzumab Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Pertuzumab Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Pertuzumab Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Pertuzumab Sales (MT), 2016-2021
Table 22. By Application - United States Pertuzumab Sales (MT), 2022-2027
Table 23. Novartis AG Corporation Information
Table 24. Novartis AG Description and Major Businesses
Table 25. Novartis AG Pertuzumab Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 26. Novartis AG Pertuzumab Product
Table 27. Novartis AG Recent Developments
Table 28. Pfizer Corporation Information
Table 29. Pfizer Description and Major Businesses
Table 30. Pfizer Pertuzumab Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 31. Pfizer Pertuzumab Product
Table 32. Pfizer Recent Developments
Table 33. Abnova Corporation Corporation Information
Table 34. Abnova Corporation Description and Major Businesses
Table 35. Abnova Corporation Pertuzumab Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 36. Abnova Corporation Pertuzumab Product
Table 37. Abnova Corporation Recent Developments
Table 38. InvivoGen Corporation Information
Table 39. InvivoGen Description and Major Businesses
Table 40. InvivoGen Pertuzumab Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 41. InvivoGen Pertuzumab Product
Table 42. InvivoGen Recent Developments
Table 43. Celltrion Corporation Information
Table 44. Celltrion Description and Major Businesses
Table 45. Celltrion Pertuzumab Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 46. Celltrion Pertuzumab Product
Table 47. Celltrion Recent Developments
Table 48. Biocon Limited Corporation Information
Table 49. Biocon Limited Description and Major Businesses
Table 50. Biocon Limited Pertuzumab Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 51. Biocon Limited Pertuzumab Product
Table 52. Biocon Limited Recent Developments
Table 53. Bio-Techne Corporation Information
Table 54. Bio-Techne Description and Major Businesses
Table 55. Bio-Techne Pertuzumab Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 56. Bio-Techne Pertuzumab Product
Table 57. Bio-Techne Recent Developments
Table 58. Pertuzumab Production Capacity (MT) of Key Manufacturers in United States Market, 2019-2021 (MT)
Table 59. United States Pertuzumab Capacity Market Share of Key Manufacturers, 2019-2021
Table 60. Pertuzumab Market Opportunities & Trends in United States Market
Table 61. Pertuzumab Market Drivers in United States Market
Table 62. Pertuzumab Market Restraints in United States Market
Table 63. Pertuzumab Raw Materials
Table 64. Pertuzumab Raw Materials Suppliers in United States Market
Table 65. Typical Pertuzumab Downstream
Table 66. Pertuzumab Downstream Clients in United States Market
Table 67. Pertuzumab Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Pertuzumab Product Picture
Figure 2. Pertuzumab Segment by Type
Figure 3. Pertuzumab Segment by Application
Figure 4. United States Pertuzumab Market Overview: 2020
Figure 5. United States Pertuzumab Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Pertuzumab Revenue, 2016-2027 (US$, Mn)
Figure 7. Pertuzumab Sales in United States Market: 2016-2027 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Pertuzumab Revenue in 2020
Figure 9. Human Source Product Picture
Figure 10. Animal Source Product Picture
Figure 11. By Type - United States Pertuzumab Sales Market Share, 2016-2027
Figure 12. By Type - United States Pertuzumab Revenue Market Share, 2016-2027
Figure 13. By Type - United States Pertuzumab Price (USD/MT), 2016-2027
Figure 14. Hospital
Figure 15. Medical Center
Figure 16. By Application - United States Pertuzumab Sales Market Share, 2016-2027
Figure 17. By Application - United States Pertuzumab Revenue Market Share, 2016-2027
Figure 18. By Application - United States Pertuzumab Price (USD/MT), 2016-2027
Figure 19. Novartis AG Pertuzumab Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. Pfizer Pertuzumab Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Abnova Corporation Pertuzumab Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. InvivoGen Pertuzumab Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Celltrion Pertuzumab Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Biocon Limited Pertuzumab Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Bio-Techne Pertuzumab Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. United States Pertuzumab Production Capacity (MT), 2016-2027
Figure 27. Pertuzumab Industry Value Chain
Figure 28. Marketing Channels
  • China Ocular Drug Delivery Market Report & Forecast 2021-2027
    Published: 26-Oct-2021        Price: US 3400 Onwards        Pages: 91
    China Ocular Drug Delivery Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Doses) China Ocular Drug Delivery Market Segment Percentages, By Type, 2020 (%) - Ocular Insert - Iontophoresis - Intraocular Implants - In Situ Gel & Punctal Plugs - Others China Ocular Drug Delivery Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Doses) China Ocular Drug Delivery Market Segment Percentages, By Application, 2020 (%)......
  • China Nuclear Medicine/Radiopharmaceutic Market Report & Forecast 2021-2027
    Published: 26-Oct-2021        Price: US 3400 Onwards        Pages: 93
    China Nuclear Medicine/Radiopharmaceutic Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (Kiloton) China Nuclear Medicine/Radiopharmaceutic Market Segment Percentages, By Type, 2020 (%) - Tc-99 - I-123/131 - In-111 - Xe-133 - Th-201 - Ga-67 - Other China Nuclear Medicine/Radiopharmaceutic Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (Kiloton) China Nuclear Medicine/Radiopharmaceutic Market Segment P......
  • China NSAIDs Market Report & Forecast 2021-2027
    Published: 26-Oct-2021        Price: US 3400 Onwards        Pages: 90
    China NSAIDs Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) China NSAIDs Market Segment Percentages, By Type, 2020 (%) - Aspirin - Ibuprofen - Naproxen - Nabumetone - Others China NSAIDs Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) China NSAIDs Market Segment Percentages, By Application, 2020 (%) - Back Pain Treatment - Osteoarthritis Treatment - Other Disease Treatment......
  • China Non-Tyrosine Kinase Inhibitors Market Report & Forecast 2021-2027
    Published: 26-Oct-2021        Price: US 3400 Onwards        Pages: 107
    China Non-Tyrosine Kinase Inhibitors Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) China Non-Tyrosine Kinase Inhibitors Market Segment Percentages, By Type, 2020 (%) - mTOR Inhibitors - RAF/MEK Inhibitors - CDK Inhibitors China Non-Tyrosine Kinase Inhibitors Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) China Non-Tyrosine Kinase Inhibitors Market Segment Percentages, By Application, 2020 (%) - Liver Can......
  • China Nonsteroidal Antiinflammatory Drugs Market Report & Forecast 2021-2027
    Published: 26-Oct-2021        Price: US 3400 Onwards        Pages: 90
    China Nonsteroidal Antiinflammatory Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) China Nonsteroidal Antiinflammatory Drugs Market Segment Percentages, By Type, 2020 (%) - Oral Nonsteroidal Antiinflammatory Drugs - Injection Nonsteroidal Antiinflammatory Drugs China Nonsteroidal Antiinflammatory Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) China Nonsteroidal Antiinflammatory Drugs Market Segment Percenta......
  • China Non-opioid Pain Patch Market Report & Forecast 2021-2027
    Published: 26-Oct-2021        Price: US 3400 Onwards        Pages: 107
    China Non-opioid Pain Patch Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Units) China Non-opioid Pain Patch Market Segment Percentages, By Type, 2020 (%) - Lidocaine Patches - Diclofenac Patches - Indomethacin Patches - Counter-Irritant Patches - Fentanyl Patches - Others China Non-opioid Pain Patch Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Units) China Non-opioid Pain Patch Market Segment Perc......
  • China Non Narcotic Analgesics Market Report & Forecast 2021-2027
    Published: 26-Oct-2021        Price: US 3400 Onwards        Pages: 92
    China Non Narcotic Analgesics Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) China Non Narcotic Analgesics Market Segment Percentages, By Type, 2020 (%) - Non Steroid Antiinflammatory Drug - Steroid Antiinflammatory Drug China Non Narcotic Analgesics Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) China Non Narcotic Analgesics Market Segment Percentages, By Application, 2020 (%) - Hospital - Medical Center......
  • Global Azelastine Nasal Spray Market Research Report 2021
    Published: 26-Oct-2021        Price: US 2900 Onwards        Pages: 100
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - 0.137MG/SPRAY - 0.2055MG/SPRAY - Other Segment by Application - Hospital - Ret......
  • Global Azelastine Drug Market Research Report 2021
    Published: 26-Oct-2021        Price: US 2900 Onwards        Pages: 114
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Nasal Spray - Eye Drops - Other Segment by Application - Hospital - Retail Pha......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs